discharge that, at times, was prolonged and confined to a limited number of electrodes (1, 2) . In some cases, especially when the description of the aura or the clinical symptom(s) of the seizure(s) are atypical, scalp-negative seizures may constitute a diagnostic conundrum to clinicians, as the lack of EEG correlates raises the possibility of these seizures being a nonepileptic phenomenon, that is, psychogenic nonepileptic seizures or PNES (3) . So, the main question is, how does this study help us to manage our patients and what is the value of this study for the broader question of clinical investigations in epilepsy?
Patients reporting seizures typically undergo detailed evaluation that includes routine or extended EEG. When the seizures continue to occur, despite adequate trials of AEDs, prolonged video/EEG monitoring may help in solving the diagnostic dilemma. But what if the patient has scalp-negative seizures that are not nonepileptic? What if we diagnose the patient with scalp-negative seizures with PNES instead and,
Widespread Changes in Network Activity Allow Non-Invasive Detection of Mesial Temporal Lobe Seizures.
Lam AD, Zepeda R, Cole AJ, Cash SS. Brain. 2016;139:2679-2693.
Decades of experience with intracranial recordings in patients with epilepsy have demonstrated that seizures can occur in deep cortical regions such as the mesial temporal lobes without showing any obvious signs of seizure activity on scalp electroencephalogram. Predicated on the idea that these seizures are purely focal, currently, the only way to detect these 'scalp-negative seizures' is with intracranial recordings. However, intracranial recordings are only rarely performed in patients with epilepsy, and are almost never performed outside of the context of epilepsy. As such, little is known about scalp-negative seizures and their role in the natural history of epilepsy, their effect on cognitive function, and their association with other neurological diseases. Here, we developed a novel approach to non-invasively identify scalp-negative seizures arising from the mesial temporal lobe based on scalp electroencephalogram network connectivity measures. We identified 25 scalp-negative mesial temporal lobe seizures in 10 patients and obtained control records from an additional 13 patients, all of whom underwent recordings with foramen ovale electrodes and scalp electroencephalogram. Scalp data from these records were used to train a scalp-negative seizure detector, which consisted of a pair of logistic regression classifiers that used scalp electroencephalogram coherence properties as input features. On cross-validation performance, this detector correctly identified scalp-negative seizures in 40% of patients, and correctly identified the side of seizure onset for each seizure detected. In comparison, routine clinical interpretation of these scalp electroencephalograms failed to identify any of the scalp-negative seizures. Among the patients in whom the detector raised seizure alarms, 80% had scalp-negative mesial temporal lobe seizures. The detector had a false alarm rate of only 0.31 per day and a positive predictive value of 75%. Of the 13 control patients, false seizure alarms were raised in only one patient. The fact that our detector specifically recognizes focal mesial temporal lobe seizures based on scalp electroencephalogram coherence features, lends weight to the hypothesis that even focal seizures are a network phenomenon that involve widespread neural connectivity. Our scalp-negative seizure detector has clear clinical utility in patients with temporal lobe epilepsy, and its potential easily translates to other neurological disorders, such as Alzheimer's disease, in which occult mesial temporal lobe seizures are suspected to play a significant role. Importantly, our work establishes a novel approach of using computational approaches to non-invasively detect deep seizure activity, without the need for invasive intracranial recordings.
The Man Versus the Machine: The Machine Wins the Race to Detect the Scalp-Negative Seizures
therefore, effectively deny the patient needed treatment? In addition to invasive monitoring, is there a different way of evaluating these patients? Possibly so, but how realistic would it be for clinical staff in an epilepsy center to implement and routinely conduct the analyses performed by Lam et al.?
These authors devised a mathematically and statistically sophisticated data analysis strategy based on scalp EEG coherence characteristics of data obtained from a convenience sample of patients whose seizures, at least some of them, were scalp negative but who also underwent, as part of their presurgical evaluation, placement of foramen ovale electrodes (no breech of skull vault) that allowed unequivocal identification of the EEG events. They first used EEG datasets from these patients to develop appropriate data classifiers to train the machine. Next, a scalp-negative seizure detector based on coherence properties performed cross-validation of the method. Final detection parameters identified correctly the scalp-negative seizures in 40% of patients with a low false detection rate of less than one per day; overall, 8/25 scalp-negative seizures were detected correctly. While the sensitivity of this method appears to be low, we need to remember that the scalp EEGs of these patients were deemed normal by a group of highly skilled clinical interpreters. Thus, while a far cry from perfection, it appears that the use of the machine provided an improvement over the visual interpretation of the recordings. Further, beyond detecting the scalp-negative seizures, the study taught us something new: Scalp-negative seizures, despite EEG change confined to one or few depth electrodes, exert an effect on widespread brain networks that can be identified with this or other types of analyses. While the existence of such effects has been widely recognized and researched in patients with dyscognitive seizures since the "nociferous cortex hypothesis" was initially presented by Hermann and colleagues (4), this is likely the first evidence of scalp (and mostly clinically) negative seizures exerting similar effects at the level of the EEG.
To some, this study will raise fears of the machines replacing trained epileptologists in the future. As of today, this is a very unlikely possibility. However, more likely, various, such as neuroimaging or neuropsychological data-will be devised and used in the future to supplement clinical review and interpretation, providing valuable information about the effects of disease state on brain networks (5) . Machine learning algorithms and other types of analyses are here to stay and help us with the increasingly complex medical technology and patient presentations. Beyond that, the study raises several interesting questions:
1. Can this method, as suggested by the authors, be easily translated into a user-friendly interface that can be implemented across the epilepsy centers for validation and then used to process routine scalp recordings in patients who report unusual symptoms and who may have "scalpnegative seizures"?
2. Can the sensitivity of this method be improved while specificity remains at the current level?
3. How can we apply this and other analysis methods to the investigations of patient-specific networks that may or may not be involved in seizure generation and propagation to provide better and more targeted treatments (e.g., neuromodulation or neurostimulation)?
4. What is the utility of this method in evaluating patients who do not have epilepsy but who are at high risk of developing it and are reporting unusual and medically unexplained symptoms, such as patients with neurodegenerative disorders or brain tumors?
5. Finally, should the detection of the presumed to be scalpnegative seizures change the management of the patient? How do we assure that we not change the management in response to a false alarm? After all, we all swore to uphold the Hippocratic Oath with its centerpiece-"primum non nocere. "
Fear of the machines replacing the epileptologists in the near future are, in my opinion, unsubstantiated. The sensitivity and specificity of this and other machine learning techniques of automated data processing are still too low to justify automated and unsupervised EEG analyses (6) . This study was not designed to answer these questions but rather to pose them and stimulate new avenues of research that may result in substantial changes to the diagnosis and management of our patients. So, stay tuned and don't despair: Machines are here . . . to help us better manage our patients, not to replace us.
by Jerzy P. Szaflarski, MD, PhD
